ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) REPORT ON ANNUAL GENERAL MEETING PROCEEDINGS Shareholders are advised that, at the Annual General Meeting (“AGM”) of members held on Thursday, 8 December 2022, a total of 336 222 144 or 75,34% of issued shares (446 252 332) were voted. All ordinary and special resolutions were passed by the requisite majority votes, except for the non-binding advisory vote relating to the endorsement of the implementation report. The full voting statistics from this AGM are confirmed to be as follows: 1 Ordinary resolution number 1: Presentation and adoption of Annual Financial Statements For Against Abstain Shares voted 335 169 995 1 588 1 050 561 335 171 583 100,00% 0,00% 0,24% 75,11% 2 Ordinary resolution number 2: Presentation and noting of the Social & Ethics Committee Report For Against Abstain Shares voted 334 932 980 240 541 1 048 623 335 173 521 99,93% 0,07% 0,23% 75,11% 3 Ordinary resolution number 3.1: Re-election of Kuseni Dlamini retiring by rotation and available for re-election For Against Abstain Shares voted 288 739 069 47 264 510 218 565 336 003 579 85,93% 14,07% 0,05% 75,29% 4 Ordinary resolution number 3.2: Re-election of Linda de Beer retiring by rotation and available for re-election For Against Abstain Shares voted 316 060 625 19 945 588 215 931 336 006 213 94,06% 5,94% 0,05% 75,30% 5 Ordinary resolution number 3.3: Re-election of Chris Mortimer retiring by rotation and available for re-election For Against Abstain Shares voted 305 598 715 30 404 426 219 003 336 003 141 90,95% 9,05% 0,05% 75,29% 6 Ordinary resolution number 3.4: Re-election of Yvonne Muthien retiring by rotation and available for re-election For Against Abstain Shares voted 334 242 987 1 760 154 219 003 336 003 141 99,48% 0,52% 0,05% 75,29% 7 Ordinary resolution number 3.5: Re-election of David Redfern retiring by rotation and available for re-election For Against Abstain Shares voted 333 032 459 2 970 690 218 995 336 003 149 99,12% 0,88% 0,05% 75,29% 8 Ordinary resolution number 4: Reappointment of Ernst & Young Inc. as independent external auditors For Against Abstain Shares voted 335 995 450 10 370 216 324 336 005 820 100,00% 0,00% 0,05% 75,30% 9 Ordinary resolution number 5.1: Election of Linda de Beer as a member of the Audit & Risk Committee For Against Abstain Shares voted 333 758 452 2 245 679 218 013 336 004 131 99,33% 0,67% 0,05% 75,29% 10 Ordinary resolution number 5.2: Election of Ben Kruger as a member of the Audit & Risk Committee For Against Abstain Shares voted 333 414 582 2 590 674 216 888 336 005 256 99,23% 0,77% 0,05% 75,29% 11 Ordinary resolution number 5.3: Election of Babalwa Ngonyama as a member of the Audit & Risk Committee For Against Abstain Shares voted 333 200 015 2 803 679 218 450 336 003 694 99,17% 0,83% 0,05% 75,29% 12 Ordinary resolution number 6: Unissued shares placed under the control of directors (5%) For Against Abstain Shares voted 307 542 529 28 461 602 218 013 336 004 131 91,53% 8,47% 0,05% 75,29% 13 Ordinary resolution number 7: General but restricted authority for the directors to issue shares for cash (5%) For Against Abstain Shares voted 304 284 371 31 720 070 217 703 336 004 441 90,56% 9,44% 0,05% 75,29% 14 Ordinary resolution number 8: Authorisation for an Executive Director to sign necessary documents For Against Abstain Shares voted 335 867 253 136 635 218 256 336 003 888 99,96% 0,04% 0,05% 75,29% 15 Non-binding advisory resolution number 1: Endorsement of the remuneration policy by way of a non-binding advisory vote For Against Abstain Shares voted 310 581 922 25 421 349 218 873 336 003 271 92,43% 7,57% 0,05% 75,29% 16 Non-binding advisory resolution number 2: Remuneration implementation report For Against Abstain Shares voted 231 439 198 104 564 565 218 381 336 003 763 68,88% 31,12% 0,05% 75,29% 17 Special resolution number 1.1a: Remuneration of non-executive directors – Chairman For Against Abstain Shares voted 334 948 749 1 042 738 230 657 335 991 487 99,69% 0,31% 0,05% 75,29% 18 Special resolution number 1.1b: Remuneration of non-executive directors – Board Member For Against Abstain Shares voted 335 603 631 387 856 230 657 335 991 487 99,88% 0,12% 0,05% 75,29% 19 Special resolution number 1.2a: Remuneration of non-executive directors – Audit & Risk Committee Chairman For Against Abstain Shares voted 335 604 981 385 804 231 359 335 990 785 99,89% 0,11% 0,05% 75,29% 20 Special resolution number 1.2b: Remuneration of non-executive directors – Audit & Risk Committee Member For Against Abstain Shares voted 335 604 981 386 506 230 657 335 991 487 99,88% 0,12% 0,05% 75,29% 21 Special resolution number 1.3a: Remuneration of non-executive directors – Remuneration & Nomination Committee Chairman For Against Abstain Shares voted 335 604 183 387 304 230 657 335 991 487 99,88% 0,12% 0,05% 75,29% 22 Special resolution number 1.3b: Remuneration of non-executive directors – Remuneration & Nomination Committee Member For Against Abstain Shares voted 335 603 481 388 006 230 657 335 991 487 99,88% 0,12% 0,05% 75,29% 23 Special resolution number 1.4a: Remuneration of non-executive directors – Social & Ethics Committee Chairman For Against Abstain Shares voted 335 603 481 388 904 229 759 335 992 385 99,88% 0,12% 0,05% 75,29% 24 Special resolution number 1.4b: Remuneration of non-executive directors – Social & Ethics Committee Member For Against Abstain Shares voted 335 603 481 389 606 229 057 335 993 087 99,88% 0,12% 0,05% 75,29% 25 Special resolution number 2: Financial assistance to related or inter-related company For Against Abstain Shares voted 321 642 716 14 364 025 215 403 336 006 741 95,73% 4,27% 0,05% 75,30% 26 Special resolution number 3: General authority to repurchase shares For Against Abstain Shares voted 325 247 278 10 745 664 229 202 335 992 942 96,80% 3,20% 0,05% 75,29% In view of the dissenting votes received in respect of the non-binding advisory vote on the remuneration implementation report (item 16 above – Non-binding advisory resolution number 2), the company invites shareholders who voted against this non-binding advisory vote to either confirm that further engagement about these aspects is sought or to make written submissions regarding their concerns on these aspects to the Company Secretary, Riaan Verster (rverster@aspenpharma.com), by close of business on Friday, 27 January 2023. Meetings with these dissenting shareholders will be arranged, as appropriate, thereafter. Durban 08 December 2022 Sponsor Investec Bank Limited